NIAID/DCR Clinical Research Support

NIH Pandemic-Era Grants

Pandemic Era Grants

2020

↗ Live URL (may be dead)

Document text

Principal Investigator: Mary  Smolskis
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2020
Award: $5,310,817
Funding agency: National Institute of Allergy and Infectious Diseases

The NIAID Division of Clinical Research (DCR) rapidly deployed resources to support collaborative clinical research.  In support of multiple COVID-19 clinical trials, the DCR Integrated Research Facility at Fort Detrick, MD provided testing of plasma, serum, and purified antibodies for neutralization against authentic SARS-CoV-2.  Trials supported included the INSIGHT 013 trial, ACTT trials, and the ACTIV-3 trial.  Additional DCR support included travel for a limited number of employees to Far East.

Terms: <2019 novel coronavirus><2019-nCoV><Blood Plasma><COVID-19><COVID-19 epidemic><COVID-19 pandemic><COVID19><COVID19 epidemic><COVID19 pandemic><Clinical Research><Clinical Study><Clinical Trials><CoV emergence><Conduct Clinical Trials><Coronaviridae><Coronavirus><Department of Health and Human Services><Disease><Disease Outbreaks><Disorder><East Asia><Eastern Asia><Employee><Far East><Government><Health><International><Mission><Municipalities><NIAID><NIH><National Institute of Allergy and Infectious Disease><National Institutes of Health><Non-Polyadenylated RNA><Outbreaks><Patients><Plasma><Plasma Serum><RNA><RNA Gene Products><Research Resources><Research Support><Resources><Reticuloendothelial System, Serum, Plasma><Ribonucleic Acid><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe acute respiratory syndrome coronavirus 2><Testing><Time><Travel><United States Department of Health and Human Services><United States Dept. of Health and Human Services><United States National Institutes of Health><Viral Pneumonia><Virus><Wuhan coronavirus><corona virus><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 epidemic><coronavirus disease 2019 pandemic><coronavirus emergence><emergent CoV><emergent coronavirus><emerging CoV><emerging coronavirus><global health><nCoV><neutralizing antibody><new CoV><new coronavirus><novel CoV><novel coronavirus><prevent><preventing><research facility><respiratory><response>